Pharma Journalist -

NHS patients to benefit from Europe’s first full access deal on breakthrough CAR-T therapy. NHS England chief executive Simon Stevens has announced today that children and young…
Read More...

DZS Clinical Services, which provides clinical development and data analytic services for global pharmaceutical, biotech and medical device companies, announced that it has been…
Read More...

WuXi AppTec congratulates its partner Hutchison MediPharma (HMP) on receiving approval of fruquintinib capsules (Elunate) for metastatic colorectal cancer from the National Medical…
Read More...

Atara Biotherapeutics announced that it has entered into a strategic collaboration with Moffitt Cancer Center to develop multi‑targeted chimeric antigen receptor T-cell (CAR T)…
Read More...

Thrombolytic Science, LLC (TSI) announced initiation of a Phase 2 clinical trial to confirm the efficacy and safety of its sequential dual-treatment regimen of low-dose tissue…
Read More...

ADMA Biologics, a vertically integrated commercial biopharmaceutical company that manufactures, markets and develops specialty plasma-based biologics for the prevention and treatment of…
Read More...

SMi Reports: SMi’s Immuno-Oncology Conference is taking place in just under 4 weeks in London, where industry-leading experts will gather to discuss the potential of Immuno-Therapy as…
Read More...

Pfizer announced its investigational oral Janus kinase 3 (JAK3) inhibitor PF-06651600 received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for the…
Read More...

AMRI and Metrion Biosciences announced that they have signed a new collaboration agreement. The alliance will promote Metrion's electrophysiology and ion channel screening expertise to…
Read More...

Merck announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a new supplemental Biologics License Application (sBLA) seeking accelerated…
Read More...